Home › Amgen buying cancer drug maker Onyx for $10.4B
 

Keywords :   


Amgen buying cancer drug maker Onyx for $10.4B

2013-08-27 15:03:04| Chemicals - Topix.net

Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash in a deal that will add several cancer drugs to Amgen's stable and boost its pipeline of new drugs.

Tags: drug buying cancer maker

Category:Chemicals

Latest from this category

All news
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
04.10RPM General Counsel Edward W. Moore to Retire
04.10AkzoNobel to Review Portfolio with Early Focus on Deco South Asia
03.10AkzoNobel Goes Extra Mile to Help Residents of Worlds Highest Motorable Village
03.10PPG Wins 2024 Supplier Excellence Award from Caterpillar Inc.
02.10RPM Reports Record Fiscal 1Q 2025 Results
02.10Evonik Breaks Ground on Major Silica Expansion at Charleston
01.10BCF CEO Tom Bowtell is Honored for Outstanding Leadership
Chemicals »
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Hurricane Milton Graphics
07.10Hurricane Leslie Forecast Discussion Number 19
07.10Hurricane Milton Forecast Discussion Number 7
07.10Hurricane Milton Wind Speed Probabilities Number 7
07.10Hurricane Leslie Graphics
07.10Hurricane Milton Forecast Advisory Number 7
More »